No. 5: Medallia (MDLA)
Medallia is a software company that owns and operates a customer survey and feedback management platform called the Medallia Experience Cloud. The firm’s market debut follows a string of successful listings from tech unicorns, including most recently Slack Technologies Inc. (WORK) whose shares are up nearly 34% from the June 19 IPO. Medallia was founded in 2001 and raked in sales of $337 million from April 2018 to April 2019 on top of over $330 million in funding from investors like Saints Capital, TriplePoint Venture Growth and Sequoia Capital.
The company is set to raise $247 million by selling 14.5 million shares at a price range of $16 to $18. At the midpoint of that range, Medallia would command a public market cap of $2.8 billion. Bank of America Merrill Lynch and Citigroup Inc. (C) are the deal’s primary bookrunners, and shares of Medallia will trade on the New York Stock Exchange (NYSE) under the ticker “MDLA.”
No. 4: AssetMark Financial Holdings (AMK)
AssetMark is a financial tech firm offering a wealth management platform to help independent financial advisers. According to the company’s statements, the platform lets advisers operating on a smaller budget outsource office support services that may be expensive or require significant time investments, which achieves the firm’s goal of “helping to level the playing field for independent financial advisers of all sizes.” It was bought by Chinese money manager Huatai Securities for $780 million in 2016 and will now be spun off as its own stock.
By offering 12.5 million shares between $19 and $21 apiece, AssetMark will effectively generate $250 million at the range’s midpoint and target a $1.45 billion market cap. The deal’s underwriters include JPMorgan Chase & Co. (JPM), Goldman Sachs Group Inc. (GS), and Credit Suisse Group AG (CS). The stock will trade on the NYSE under the ticker “AMK.”
No. 3: Intercorp Financial Services Inc. (IFS)
Boasting revenue of $1.5 billion last year, Intercorp is one of Peru’s largest banking, insurance, and wealth-management companies. It’s already publicly traded on the Lima Stock Exchange in Peru and the Frankfurt Stock Exchange in Germany, whose European shares are up more than 17% year-to-date.
Intercorp is set for a $423 million debut by selling 9 million shares for somewhere in the wide $44 to $50 range. If shares price at the $47 midpoint, the company would assume a market cap of $5.37 billion. The lead underwriters are Bank of America Merrill Lynch and JPMorgan, and shares will list on the NYSE under the ticker “IFS.”
No. 2: Genmab A/S (GMAB)
Genmab is a Danish biotech primarily developing treatments for cancer and several other illnesses. The company’s product candidates include daratumumab and ofatumumab, respectively used to treat multiple myeloma and chronic leukemia. It was founded in 1998 and just earned revenue of $441 million between March 2018 and March 2019.
Genmab is expected to generate $503 million by selling 27.8 million shares at a $18.11 price point, giving the firm an $11.79 billion market cap. Bank of America Merrill Lynch and Morgan Stanley (MS) are bookrunning the deal. Genmab will debut on the Nasdaq under the ticker “GMAB.”
No. 1: DouYou International Holdings (DOYU)
The week’s largest IPO and third debut from a foreign company is DoYou, which runs China’s largest live e-sports streaming platform. In the fourth quarter of 2017 and 2018, the company respectively logged 134.3 million and 153.5 million monthly active users (MAUs), while users on average spent 17.2 million and 24.2 million hours on the platform during those same time periods. DoYou is backed by Chinese tech giant Tencent Holdings Ltd. and individually brought in sales of $651 million from March 2018 to March 2019.
DoYou is set for an $859 million deal and will offer 67.39 million shares between $11.50 and $14 apiece. At the midpoint, the company will command a $4.41 billion market cap. Morgan Stanley and JPMorgan are the lead underwriters, and shares will debut on the Nasdaq under the ticker “DOYU.”